Jemielita, T., Tse, A., & Chen, C. (2020). Oncology phase II proof‐of‐concept studies with multiple targets: Randomized controlled trial or single arm? Pharmaceutical Statistics, 19(2), 117. https://doi.org/10.1002/pst.1972
Chicago Style (17th ed.) CitationJemielita, Thomas, Archie Tse, and Cong Chen. "Oncology Phase II Proof‐of‐concept Studies with Multiple Targets: Randomized Controlled Trial or Single Arm?" Pharmaceutical Statistics 19, no. 2 (2020): 117. https://doi.org/10.1002/pst.1972.
MLA (9th ed.) CitationJemielita, Thomas, et al. "Oncology Phase II Proof‐of‐concept Studies with Multiple Targets: Randomized Controlled Trial or Single Arm?" Pharmaceutical Statistics, vol. 19, no. 2, 2020, p. 117, https://doi.org/10.1002/pst.1972.
Warning: These citations may not always be 100% accurate.